Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive Neoadjuvant Therapy in Localized Pancreatic Cancer
NCT03322995Phase 2Recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Jun 2018
- Primary completion
- Jun 2027
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, folinic acid, irinotecan, oxaliplatin, gemcitabine in pancreatic cancer (PC), sponsored by Medical College of Wisconsin. Started Jun 2018; status: recruiting.
02
Drugs
fluorouracilfolinic acidirinotecanoxaliplatingemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03322995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03322995.